Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing
Reexamination Certificate
2006-08-22
2006-08-22
Swartz, Rodney P (Department: 1645)
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
C424S009200, C424S184100, C424S190100, C424S191100, C424S234100, C424S263100, C424S278100, C435S069300, C530S300000, C530S350000
Reexamination Certificate
active
07094391
ABSTRACT:
Mucosal administration of OspA and compositions therefor are disclosed and claimed. More particularly, oral administration of OspA and compositions therefor for eliciting an immunological response againstBorrelia burgdorferi, such as a protective response preventive of Lyme disease are disclosed and claimed. Thus, oral Lyme disease vaccines or immunological compositions and methods of use are disclosed and claimed.
REFERENCES:
patent: 4320115 (1982-03-01), Bijlenga
patent: 5178859 (1993-01-01), Simon et al.
patent: 5523089 (1996-06-01), Bergstrom et al.
patent: 90/02282 (1990-03-01), None
patent: 92/00055 (1992-01-01), None
Wilske et al Annals of the New York Academy of Sciences 539: 126-143, 1988.
Benach et al The Journal of Immunology 140: 265-272, 1988.
Burgess, EC. Annals of New York Academy of Sciences, vol. 539. 1988 pp. 235-243.
SN Cohen. Immunization. Chapter 43 in: Basic & Clinical Immunology, 3rd ed. Fudenberg HH, Stites DP, Caldwell JL, Wells JV (editors). Lange Medical Publications, 1980.
Yoshimura, H., et al. “Oral vaccine therapy for pneumococcal otitis media in an animal model.” Archives of Otolaryngology Head and Neck Surgery, vol. 117, No. 8, pp. 889-894, 1991.
Muir, W., et al. “Induction of specific IgA responses in rats after oral vaccination with biodegradable microspheres containing a recombinant protein.” Immunology Letters, vol. 42, No. 3, pp. 203-207, 1994.
Valentine, P.J., et al. “Induction of SIV capsid-specific CTL and mucosal sIgA in mice immunized with a recombinantS. typhimurium aroAmutant.” Vaccine, vol. 14, No. 2, pp. 138-146, 1996.
Fujihashi, K., et al. “Gamma/delta T cell-deficient mice have impaired mucosal immunoglobulin A responses.” Journal of Experimental Medicine, vol. 183, No. 4, pp. 1929-1935, 1996.
Tuboly, T., et al. “Potential viral vectors for the stimulation of mucosal antibody responses against enteric viral antigens in pigs.” Research in Veterinary Science, vol. 54, No. 3, pp. 345-350, 1993.
Crawford, M. “Wistar proposes U.S. test of rabies vaccine.” Science, vol. 240, No. 4854, p. 877(1), May 13, 1998.
Dev. Biol. Stand., vol. 41, pp. 141-148, 1978.
Barbour Alan G.
Luke Catherine J.
Frommer Lawrence & Haug
Kowalski Thomas J.
Swartz Rodney P
The University of Texas System
LandOfFree
Compositions and methods for administering Borrelia... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for administering Borrelia..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for administering Borrelia... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3664735